No. |
Research Title |
Investigator |
Status |
1 |
AEGIS II – A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subject with Acute Coronary Syndrome |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
2 |
APPIRED III – Preventing Oxidative Stress Induced Ischemic Injury and Systemic Inflammation Complications During and After Invasive Cardiac Surgery with Alkaline Phosphatase |
Dr. Pau Kiew Kong |
Enrollment |
3 |
BIOFREEDOM – Asian Registry of the BioFreedom™ BA9™ Drug-Coated Coronary Stent for Patients with ST Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI) |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
4 |
BIOSOLVE -IV – Safety and Performance in de Novo Lesion of NatiVE Coronary Arteries with Magmaris-Registry |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
5 |
CRYO-AF– Cryo AF Global Registry Study |
Dr. Surinder Kaur Khelae |
Enrollment |
6 |
CTQJ230A12001 – Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients with Established Cardiovascular Disease |
Datuk Dr. Ahmad Khairuddin Mohamed Yusof |
Enrollment |
7 |
DE NOVO – Treatment of Coronary De-Novo Stenosis by A Sirolimus Coated Balloon or A Paclitaxel Coated Balloon Catheter |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
8 |
DEDICATE REGISTRY – A Post Market Registry of Abluminum® Sirolimus Eluting Coronary Stent System for Percutaneous Intervention in Patients with Diabetic Mellitus |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
9 |
EASTBOURNE – The All-comers Sirolimus Coated Balloon European Registry: |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
10 |
FIM-IBS – A Prospective, Non-randomized, Open lable, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System |
Dr. Shaiful Azmi Yahaya |
Enrollment |
11 |
NALURI – The Effectiveness of a Personalised Malaysian Digital Health Intervention (Naluri) on Physical and Psychological Outcomes among Cardiac Patients at the Malaysian National Institute: A Randomized Controlled Trial |
Dato’ Dr. Azmee Mohd Ghazi |
Enrollment |
12 |
PROTECT-ICD – Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction |
Dr. Surinder Kaur Khelae |
Enrollment |
13 |
SELECT – Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
14 |
SELEXIPAG – A Prospective, Multicentre, Open Label, Single Arm, Phase 2 Study to Investigate the Safety, Tolerability and Pharmacokinetics of Selexipag in Children with Pulmonary Arterial Hypertention |
Dr. Geetha A/P Kandavello @ Kandhavel |
Enrollment |
15 |
TOMORROW – A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children with Pulmonary Arterial Hypertension |
Dr. Geetha A/P Kandavello @ Kandhavel |
Enrollment |
16 |
VFAHF STUDY – Ventricle from Atrium Heart Failure Clinical Study (VFAHF) |
Dr. Azlan Hussin |
Enrollment |
|
|
|
|
No. |
Research Title |
Investigator |
Status |
1 |
AC-055-512 RETRO – A Retrospective, Multicenter Chart Review to Collect Dosing Information of PAH Background Medication in Subjects Who Participated in the AC-055-302 (SERAPHIN) Double-Blind Randomized Study |
Dr. Geetha A/P Kandavello @ Kandhavel |
Follow Up |
2 |
ACOSYM – Prospective Observational study of Lipid management in South East Asian Patients who have a Recent Acute Coronary Syndrome Event |
Dr. Emily Lay Koon Tan |
Follow Up |
3 |
ASIAN HF – Asian Sudden Cardiac Death in Heart Failure (ASIAN HF) Prospective Observational Registry |
Dato’ Dr Azmee Mohd Ghazi |
Follow Up |
4 |
ASQuad – Attain StabilityTM Quad Clinical Study |
Dr. Azlan Hussin |
Follow Up |
5 |
BIOFLOW-III Registry – Safety and Performance Registry for an all-comers Diabetic patient population with the Limus Eluting Orsiro Stent System within daily clinical practice – III |
Dr. Shaiful Azmi Yahaya |
Follow Up |
6 |
BIOLUX P-III Registry – A Prospective, International, Multi-centre, Post-market All-Comers Registry to Assess the Clinical Performance of The Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Infraguinal Arteries |
Dr. Shaiful Azmi Yahaya |
Follow Up |
7 |
CONSEQUENT ALL COMERS Registry – Clinical Post Market Clinical Follow-Up (PMCF) on Peripheral Arteries treated with Sequent ® Please OTW Paclitaxel Coated Ballon Catheter in an All Comer Patient Population |
Dr. Shaiful Azmi Yahya |
Follow Up |
8 |
GRIPHON OL – Long Term, Single-Arm, Open-Label Study, to Assess the Safety and Tolerability of ACT-293987 in Patients with Pulmonary Arterial Hypertension |
Dr. Teoh Chee Kiang |
Follow Up |
9 |
ISAR Neo – Coroflex ISAR Neo Registry in Malaysia |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
10 |
ISCHEMIA – International Study of Comparative Health Effectiveness with Medical and Invasive Approaches |
Datuk Dr. Ahmad Khairuddin Mohamed Yusof |
Follow Up |
11 |
MeRes – 1 Extend – A Prospective, Multicentre, Single arm, Open label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioreorbable Vascular Caffold System in the Treatment of de-novo Native Coronary Artery Lesions |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
12 |
MPP – Product Surveillance Registry – Multiple Point Pacing (MPP) Post Approval Study |
Dr. Azlan Hussin |
Follow Up |
13 |
Onyx ONE – A Randomized Controlled Trial with Resolute Onyx in One Month DAPT for High-Bleeding Risk Patients |
Dato’ Dr. Amin Ariff Nuruddin |
Follow Up |
14 |
PARADIGM-HF – A Multicenter Study to Evaluate Safety and Tolerability in Patients with Chronic Heart Failure and Reduced Enjection Fraction from PARADIGM-HF receiving Open Label LCZ696 |
Dr. Ng Yau Piow |
Follow Up |
15 |
PASSWORD Registry – Post market Surveillance of SeQuent® Please Neo with Scoring Ballon Lesion Preparation in Real World Patients |
Datuk Dr. Ahmad Khairuddin Mohamed Yusof |
Follow Up |
16 |
REPAIR – Right vEntricular remodeling in Pulmonary ArterIal hypeRtension A prospective, multicenter, single-arm, open-label, Phase 4 study to evaluate the effects of macitentan on Right vEntricular remodeling in Pulmonary ArterIal hypeRtension assessed by cardiac magnetic resonance imaging |
Dr. Geetha A/P Kandavello @ Kandhavel |
Follow Up |
17 |
SAMURAI – ImageReady™ MR Conditional Pacing System Clinical Study |
Dr. Surinder Kaur Khelae |
Follow Up |
18 |
UNIVERSE – A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subject 2 to 8 Years of Age after the Fontan Procedure |
Dr. Hasri Samion |
Follow Up |
19 |
VITALITY-HFpEF – A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-centre Trial to Evaluate the Efficacy and Safety of the Oral SGC Stimulator Vericiguat to Improve Physical Functioning in Activities of Daily Living in Patients with Heart Failure and Preserved Ejection Fraction |
Dr. Teoh Chee Kiang |
Follow Up |
20 |
XPLORE-1 – Prospective, Non-Randomised, Open-label Clinical Study to Assess the Safety of the Bioabsorbable Pulmonary Valve Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction |
Dato’ Seri Dr. Mohd Azhari Yakub |
Follow Up |